Stories about Medizin, Gesundheit
- 5One documentmore
DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots/PRNewswire) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and ...
moreDEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...
more- 6
Exoskeletons for industry and logistics: Ottobock presents innovations at the Hannover Messe trade show
more Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories
Munich / London / Athens (ots) - - Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment - Agreement includes further product development activities for Clinigen Limited - Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally Munich-based pharmaceutical contract ...
moreIEVA (Independent European Vape Alliance)
Health professionals should know the vaping facts
Brussels (ots) - 700,000 people in the EU die each year as a result of smoking and every second smoker dies 14 years prematurely. [1] Switching to vaping has helped millions of smokers worldwide to significantly reduce the harm to their health. The principle of harm reduction works, and millions more smokers could benefit from it. But for it to really change society, smokers need the facts: and that starts with healthcare ...
moreMiltenyi Biotec acquires biosensor company lino Biotech
Zurich (ots) - lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuring viral load in cell & gene therapy ...
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreExoskeletons shape the future of industrial and logistic jobs
morePress release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
One documentmoreDEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...
moreSuccessful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Munich / Paris / Tokyo (ots) - - Adragos Pharma now third largest pure-play CDMO in the Japanese market - Long-term agreement with Sanofi secures local healthcare supply Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading ...
more- 2
Free Access to Cancer Research Services - canSERV 1st Call for Proposals
more Janneke van der Kamp starts as new Chief Commercial Officer at Grünenthal
moreEW Nutrition showcases customer-focused solutions for the animal nutrition industry at VIV Asia 2023
Singapore (ots) - EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry. “We are constantly innovating to provide best-in-class products and programs. Our participation in VIV Asia 2023 is a good opportunity to connect with our partners over EW ...
moreFree Access to Cancer Research Services - canSERV 1st Call for Proposals
One documentmore- 2
Disruptions from Ransomware and Cyberattacks on Supply Chains and Critical Infrastructure Sharpen Focus on OT Security for 2023, TXOne Networks and Frost & Sullivan Analysis Reveals
more Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris
One documentmoreType 1 Diabetes Awareness Campaign - K1DS ARE HEROES - started
moreTime makes the difference, PI 16/2023
Time makes the difference About 18,000 physicians from Cuba came to Brazil between 2013 and 2018 during the "More Doctors for Brazil" project. The programme aimed at alleviating the public health emergency, however, initially met with surprising resistance, as Konstanz anthropologist Maria Lidola observed in Rio de Janeiro. When countries in the Global ...
One documentmoreNew study from Waltham Petcare Science Institute, part of Mars Petcare, shows cannabidiol (CBD) is effective at reducing stress in dog
WALTHAM-ON-THE-WOLDS, England (ots/PRNewswire) - - Single dose of THC-free CBD reduced stress in healthy dogs - The study, conducted by the Waltham Petcare Science Institute, was published today in Frontiers in Veterinary Science. Results from a study performed by the Waltham Petcare Science Institute published ...
moreMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
more- 2
PM: DHL Express bringt internationalen Glücksgipfel WOHASU® 2023 nach Italien / PR: WOHASU® 2023, the international event dedicated to happiness, arrives in Italy thanks to DHL Express
more Blood Donation Day at R-Biopharm: Employees Help Save Lives
morePress release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
One documentmoreBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
moreGerresheimer and Corning announce joint venture to meet growing demand for Velocity® Vials, accelerating the delivery of lifesaving treatments
Düsseldorf (ots) - Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma, biotech, and cosmetics, today announced a joint venture with Corning Incorporated (NYSE: GLW), a leading innovator in materials science and manufacturing, to increase global access to the ...
more“Koehler Cycles”—Employees Get on Their Bikes for a Good Cause
moreAccord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
London (ots/PRNewswire) - Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners from industry and the patient community to raise awareness of the importance of working ...
moreIEVA (Independent European Vape Alliance)
World Cancer Day - Decrease smoking rates with reduced-risk alternatives
Brussels (ots) - 19.7 percent of the EU population are daily smokers. [1] 700,000 people in the EU die each year as a result of smoking and every second smoker dies on average 14 years prematurely. [2] Smoking is the leading cause of preventable cancer, with 27 percent of all cancers attributed to tobacco. [3] The examples of Great Britain (smoking rate: 13.8 percent) ...
more